JPRN-UMIN000049814
Not yet recruiting
未知
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney disease - Investigating the efficacy of community pharmacy intervention on serum potassium levels in patients with chronic kidney disease
ational Hospital Organization Mie Chuo Medical Center0 sites40 target enrollmentDecember 18, 2022
Conditionschronic kidney disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- chronic kidney disease
- Sponsor
- ational Hospital Organization Mie Chuo Medical Center
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who do not agree to participate in this study 2\) Patients with communication difficulties 3\) Patients with hypokalemia (serum potassium level less than 4\.0 mmol/L) 4\) Patients on maintenance dialysis 5\) Patients who bring refill prescriptions 6\) Patients taking oral potassium preparations 7\) Patients who are not expected to continuously visit the insurance pharmacy under study for at least 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviewsadverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)NL-OMON28732Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands200
Recruiting
Not Applicable
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease ProjectACTRN12609000705280Monash450
Not yet recruiting
Not Applicable
Evaluating the feasibility and acceptability of the MedsCheck Plus service amongst community pharmacists and home-dwelling people living with dementiaACTRN12622001172796niversity of New South Wales (UNSW)25
Completed
Not Applicable
Assessment of community pharmacies' support for smoking cessation treatment in collaboration with medical institutionsSmoking cessationJPRN-UMIN000044380School of Pharmacy, Nihon University70
Active, not recruiting
Not Applicable
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA